GRC-10801

N/A

Report date: 2025/06/11 20:01:15
NME

Base Information

Drug NameGRC-10801
Drug Alias Namecannabinoid CB1 receptor antagonist (Glenmark)GRC-10389GRC-10801
ClassificationSmall molecules
Mechanisms of ActionAppetite suppressantCannabinoid CB1 receptor antagonists
TargetsCannabinoid CB1 receptor
Therapy Area/IndicationsObesity
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryIndia
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesGlenmark Pharmaceuticals Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlenmark Pharmaceuticals Ltd
Active IndicationsN/A
Inactive IndicationsObesity

Other Information

ATC CodeN/A
Related LinksN/A